Search clinical trials for: 68Ga-BNOTA-PRGD2

Total 619 results

Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients (GRGDLC)

Lung Cancer

China
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke (GRGDS)

Stroke

China
Peking Union Medical College Hospital

Unknown

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Pulmonary Fibrosis, Unspecified

China
Nanjing First Hospital, Nanjing Medical University

Recruiting

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Prostate Cancer

China
Peking University First Hospital
Xiangya Hospital of Central South University; Peking Union Medical College... and other collaborators

Unknown

A Study of Residual Curarization Incidence in China

Perioperative/Postoperative Complications | PORC (Postoperative Residual Curarization)

China
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Carcinoma, Bronchogenic | Lymphoma, Malignant | Breast Carcinoma | Cancer of Head and Neck | Soft Tissue Neoplasms | Tumors

China
Michael Graham PhD, MD
University of Iowa; Holden Comprehensive Cancer Center

Active, not recruiting

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer Metastatic

United States
Michael Graham PhD, MD
University of Iowa; Holden Comprehensive Cancer Center

Completed

68Ga PSMA in Preprostatectomy Patients

Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Neoplasm of Uncertain Behavior

United States
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Wuhan Union Hospital, China

Completed

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Healthy | Malignancy

China
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-Pentixafor PET/CT for Thymoma

Thymoma

China
PentixaPharm GmbH

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Central Hospital, Nancy, France

Unknown

Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients (TePSMAG-68)

Prostate Cancer

France
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | Theranostic

China
First Affiliated Hospital of Fujian Medical University

Completed

A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

Tumor Positron-Emission Tomography

China
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Ipsen

Terminated

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer

Austria
Xiangya Hospital of Central South University

Completed

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

Gastrointestinal Cancer

China
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
Jonsson Comprehensive Cancer Center

Completed

Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients

Neuroendocrine Carcinoma

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Chinese PLA General Hospital
Sinotau Pharmaceutical Group

Completed

First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

Malignant Solid Tumors

China
Advanced Accelerator Applications

Terminated

[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) (NeoFIND)

Breast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer

Austria, France
Peking Union Medical College Hospital

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
Peking University

Not yet recruiting

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

HER2 Positive Gastric Cancer

China
Ochsner Health System

Unknown

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Neuroendocrine Tumor | Neuroendocrine Carcinoma | Carcinoid Tumor | Neuroendocrine Cancer | Carcinoid | Islet Cell Tumor | Neuroendocrine | Apudoma

United States
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Lung Neoplasms

China
Peking Union Medical College Hospital

Recruiting

64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer

Colorectal Cancer

China
The Methodist Hospital Research Institute

Completed

68 Ga-PSMA for High Risk Prostate Cancer

Prostate Cancer | High Risk

United States
Peking University First Hospital

Recruiting

68Ga-P3 PET/CT Imaging in Prostate

Neoplasms

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Lymphedema | Hemangioma | Arteriovenous Malformation | Neoplasms Lymph Nodes

China
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Recruiting

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Myositis With 68Ga-FAPI PET/CT

Myositis | Idiopathic Inflammatory Myopathies

China
Peking Union Medical College Hospital

Recruiting

FAPI-PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

China
Peking Union Medical College Hospital

Recruiting

Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT

Arthritis

China
Peking Union Medical College Hospital

Unknown

Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT

Inflammatory Bowel Disease

China
Xiangya Hospital of Central South University

Recruiting

A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer

Prostate Cancer

China
Peking Union Medical College Hospital

Unknown

Characterizing SAPHO With 68Ga-FAPI PET/CT

SAPHO Syndrome

China
Chang Gung Memorial Hospital

Recruiting

Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

Lung Cancer

Taiwan
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI PET/MR for Atherosclerosis

Atherosclerosis

China
Peking Union Medical College Hospital

Recruiting

Characterizing IgG4-RD With 68Ga-FAPI PET/CT

IgG4-related Disease

China
Peking Union Medical College Hospital

Recruiting

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Breast Cancer | Prostate Cancer | Brain Tumor | PET/CT Imaging

China

Search clinical trials for: 68Ga-BNOTA-PRGD2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations